Merck
  • Home
  • Search Results
  • Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.

Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model.

European journal of medicinal chemistry (2011-11-22)
Miriam Redondo, Juan G Zarruk, Placido Ceballos, Daniel I Pérez, Concepción Pérez, Ana Perez-Castillo, María A Moro, José Brea, Cristina Val, María I Cadavid, María I Loza, Nuria E Campillo, Ana Martínez, Carmen Gil
ABSTRACT

A simple and efficient synthetic method for the preparation of quinazoline type phosphodiesterase 7 (PDE7) inhibitors, based on microwave irradiation, has been developed. The use of this methodology improved yields and reaction times, providing a scalable procedure. These compounds are pharmacologically interesting because of their in vivo efficacy both in spinal cord injury and Parkinson's disease models, as shown in previous studies from our group. Herein we describe for the first time that administration of one of the PDE7 inhibitors here optimized, 3-phenyl-2,4-dithioxo-1,2,3,4-tetrahydroquinazoline (compound 5), ameliorated brain damage and improved behavioral outcome in a permanent middle cerebral artery occlusion (pMCAO) stroke model. Furthermore, we demonstrate that these PDE7 inhibitors are potent anti-inflammatory as well as neuroprotective agents in primary cultures of neural cells. These results led us to propose PDE7 inhibitors as a new class of therapeutic agents for neuroprotection.

MATERIALS
Product Number
Brand
Product Description

Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Sigma-Aldrich
Hydrocortisone, meets USP testing specifications
Sigma-Aldrich
Hydrocortisone, ≥98% (HPLC)
Sigma-Aldrich
Hydrocortisone-Water Soluble, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydrocortisone, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Hydrocortisone, BioReagent, suitable for cell culture
Supelco
Testosterone, VETRANAL®, analytical standard
Supelco
Melting point standard 235-237°C, analytical standard
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder
Supelco
Hydrocortisone, VETRANAL®, analytical standard
Sigma-Aldrich
Caffeine, anhydrous, tested according to Ph. Eur.
Supelco
Mettler-Toledo Calibration substance ME 18872, Caffeine, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC)
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Piroxicam, meets USP testing specifications
Sigma-Aldrich
Caffeine, BioXtra
Sigma-Aldrich
Caffeine, powder, ReagentPlus®
Sigma-Aldrich
Caffeine, meets USP testing specifications, anhydrous
Sigma-Aldrich
Caffeine, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Hydrocortisone solution, 50 μM, sterile-filtered, BioXtra, suitable for cell culture
Supelco
Ofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
Caffeine, anhydrous, 99%, FCC, FG
Supelco
Testosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, drug standard